Literature DB >> 3759248

[Hemostatic parameters influenced by imipenem/cilastatin].

M Ziemen, P M Shah, M Henkel-Bussmann, H K Breddin.   

Abstract

Seven patients were treated for bacterial infections with imipenem/cilastatin. Imipenem is a new broad-spectrum beta-lactam antibiotic with antimicrobial activity against gram-positive and gram-negative bacilli. Before and during treatment parameters of blood coagulation and platelet function were studied. Blood coagulation was not influenced by the antibiotic. But there was a temporary inhibition of collagen-induced platelet aggregation during the first days of treatment. No clinical signs of enhanced spontaneous bleeding tendency were observed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759248     DOI: 10.1007/bf01647498

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  The hemostatic defect produced by carbenicillin.

Authors:  C H Brown; E A Natelson; W Bradshaw; T W Williams; C P Alfrey
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

2.  Letter: Coagulopathy with cefazolin in uremia.

Authors:  P I Lerner; A Lubin
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

3.  [Function of thrombocytes in hemorrhagic diathesis, thrombosis and vascular diseases].

Authors:  K Breddin
Journal:  Thromb Diath Haemorrh Suppl       Date:  1968

4.  Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function.

Authors:  E A Natelson; W T Siebert; T W Williams; M W Bradshaw
Journal:  Am J Med Sci       Date:  1979 Nov-Dec       Impact factor: 2.378

5.  Effects of cephalothin and penicillin G on platelet function in vitro.

Authors:  M A Guccione; M A Packham; J F Mustard
Journal:  Br J Haematol       Date:  1977-01       Impact factor: 6.998

6.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.

Authors: 
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

8.  Clinical experience with imipenem/cilastatin: analysis of a multicenter study.

Authors:  P M Shah
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

9.  In vitro activity of thienamycin.

Authors:  P M Shah
Journal:  Methods Find Exp Clin Pharmacol       Date:  1981 Nov-Dec

10.  Penicillin-induced coagulation disorder.

Authors:  K Andrassy; E Ritz; B Hasper; M Scherz; E Walter; H Storch
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.